Last updated on March 2018

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Brief description of study

The purpose of the proposed study is to acquire additional data (including the assessment of anti-rHuPH20 antibodies) on the long-term safety of HYQVIA and to assess the prescribed treatment regimens and treatment administration in routine clinical practice.

Clinical Study Identifier: NCT02593188

Contact Investigators or Research Sites near you

Start Over

Salvador Dominguez

Allergy & Clinical Immunology Associates
Pittsburgh, PA United States
  Connect »